Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/09/2003US20030191280 Class ii cytokine receptor-7
10/09/2003US20030191073 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
10/09/2003US20030191062 Bone marrow specific protein
10/09/2003US20030190752 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof
10/09/2003US20030190751 Directed switch-mediated DNA recombination
10/09/2003US20030190739 Tankyrase2 materials and methods
10/09/2003US20030190735 Oncoprotein protein kinase
10/09/2003US20030190732 Plasma fraction containing bikunin, method for the production thereof and use of the same
10/09/2003US20030190731 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190730 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190729 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190728 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190727 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190726 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190725 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190724 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190723 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190722 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190721 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190720 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190719 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190718 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190717 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190716 Used to produce pharmaceuticals, diagnostics, biosensors, bioreactors; PRO polypeptides
10/09/2003US20030190710 By adjusting temperature and batched medium osmolality; immunoglobulin G (IgG)
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190705 Method of humanizing immune system molecules
10/09/2003US20030190699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190698 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190685 Bind to Tumor Necrosis Factor(TNF)-Related Apoptosis Inducing Ligand (TRAIL) receptors ; used in the prevention and treatment of cancers and other proliferative disorders
10/09/2003US20030190676 In which covalently modified antibody takes on the binding specificity of a targeting agent
10/09/2003US20030190674 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
10/09/2003US20030190669 Humanized antibody.
10/09/2003US20030190668 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190667 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs)
10/09/2003US20030190614 Non-human primate Fc receptors and methods of use
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190611 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190610 Proteins involved in differentiation, maintenance of multicellular organisms, e.g. proliferation, migration, interaction of cells through drugs
10/09/2003US20030190606 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds
10/09/2003US20030190598 Used as phage display library of variable heavy domain (VHH or VH) fragments (sdAb fragments)
10/09/2003US20030190330 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis
10/09/2003US20030190323 Preparations and methods for the treatment of T cell mediated diseases
10/09/2003US20030190320 Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins
10/09/2003US20030190319 Antibodies specific for CD44v6
10/09/2003US20030190318 Immunosuppressants for treatment of autoimmune and allergic diseases; cytokines
10/09/2003US20030190317 Anti-VEGF antibodies
10/09/2003US20030190316 Comprises humanized anti-interleukin-6 receptor antibody in glycine and/or histidine buffer
10/09/2003US20030190315 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines
10/09/2003US20030190314 Administering spray dried plasma for modulating immunoglobulin levels; vaccines; for weight gain; autoimmune disorders
10/09/2003US20030190311 Immunoglobulins; fusion proteins; vaccines
10/09/2003US20030190285 Having nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions and derivatives thereof; diagnostic and therapeutic applications
10/09/2003CA2762016A1 Methods for increasing polypeptide production
10/09/2003CA2481376A1 Novel proteins and nucleic acids encoding same
10/09/2003CA2481232A1 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003CA2480661A1 A method of modulating cellular activity
10/09/2003CA2480263A1 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003CA2480163A1 Anti-il-tif antibodies and methods of using in inflammation
10/09/2003CA2480119A1 Cripto-specific antibodies
10/09/2003CA2480018A1 The functional disruption of avian immunoglobulin genes
10/09/2003CA2477268A1 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350798A1 Allergenic protein HEV b III of natural rubber latex, its production and use in assays
10/08/2003EP1350797A1 Allergenic protein Hev b II of natural rubber latex, its production and use in assays
10/08/2003EP1350521A1 Immunotherapeutic combinations for the treatment of tumors
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350113A2 Inhibition of cmv infection and dissemination
10/08/2003EP1350085A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
10/08/2003EP1349955A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
10/08/2003EP1349940A2 55562 and 21617, novel human proteins and methods of use thereof
10/08/2003EP1349939A2 Aminoacyl trna synthetases
10/08/2003EP1349935A2 Molecules for disease detection and treatment
10/08/2003EP1349933A2 Proteins and dna sequences underlying these proteins used for treating inflammations
10/08/2003EP1349931A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349928A2 A novel human g-protein coupled reciptor hgprbmy11 expressed highly in heart and variants thereof
10/08/2003EP1349924A2 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349871A2 Novel marker for the diagnosis and therapy of tumours
10/08/2003EP1349870A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
10/08/2003EP1349575A2 Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease
10/08/2003EP1349574A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
10/08/2003EP1349567A1 Compositions containing gangliosides for use in the treatment of skin disorders
10/08/2003EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0865448B1 Apoptosis induced by monoclonal antibody anti-her2
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003EP0551460B2 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV)
10/08/2003CN1447919A Use of antibodies against specific MHC-Peptide complexes
10/08/2003CN1447857A Agonist anti-TRK-C monoclonal antibodies
10/08/2003CN1447696A Gene detection assay for improving likelihood of effective response to erbb antagonist cancer therapy
10/08/2003CN1123574C Ligands for FLT3 receptors
1 ... 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 ... 1494